Patent intelligence · US
US 10093790
Three-dimensional cellulose molded body, method for the production thereof and use of the same
Three-dimensional cellulose molded body, method for the production thereof and use of the same
Patent details — US 10093790
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 9, 2018
- Expiration
- Oct 4, 2038
- Applicant
- LENZING AKTIENGESELLSCHAFT
- Claims
- 25
- CPC classes
- A61K, A61K2800/10, A61K2800/654, A61K31/167
Quick answer
US 10093790 (Three-dimensional cellulose molded body, method for the production thereof and use of the same) is held by LENZING AKTIENGESELLSCHAFT. Status: granted. Granted Oct 9, 2018. Expires Oct 4, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LENZING AKTIENGESELLSCHAFT
- Grant date
- Expiration
- Claims
- 25
- CPC classes
- A61K, A61K2800/10, A61K2800/654, A61K31/167, A61K8/0279, A61K8/731
More from LENZING AKTIENGESELLSCHAFT
Related pharmaceutical patents in our USPTO index.
-
US 12414942
Compositions, methods, and systems for treating presbyopia
granted -
US 12180206
Aceclidine derivatives, compositions thereof and methods of use thereof
granted -
US 12128036
Compositions and methods for storage stable ophthalmic drugs
granted -
US 11648247
Compositions and methods for the treatment of presbyopia
granted -
US 11344538
Methods for the treatment of myopia
granted -
US 11273150
Compositions and methods for the treatment of presbyopia
granted -
US 11214569
Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof
granted -
US 11179328
Compositions and methods for the treatment of presbyopia
granted
Frequently asked questions
What is US patent 10093790?
US 10093790 (Three-dimensional cellulose molded body, method for the production thereof and use of the same) is held by LENZING AKTIENGESELLSCHAFT. Status: granted. Granted Oct 9, 2018. Expires Oct 4, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10093790?
LENZING AKTIENGESELLSCHAFT is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 20 pharmaceutical patents for this assignee.
When does US 10093790 expire?
Our index shows an expiration date of Oct 4, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.